NASDAQ:GRFS

Grifols Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers - General

$7.35

+0.0800 (+1.10%)

At Close: Jan 21, 2025

Grifols Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 GRFS shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

ABOUT GRIFOLS

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
H HYLS $41.55	0.289%	Jan 15
ROIC $17.41	0.230%	Jan 15
V VGSH $58.23	0.0515%	Jan 15
F FALN $26.87	0.447%	Jan 15
F FTSM $59.87	0.0668%	Jan 15

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by